Why the study?
Does intravenous heparin affect plasma translucence differently in normal persons versus atherosclerotic patients during alimentary lipemia?
Does intravenous heparin affect plasma translucence differently in normal persons versus atherosclerotic patients during alimentary lipemia?
Atherosclerotic patients exhibit impaired clearing of alimentary lipemia following small doses of intravenous heparin compared to normal individuals.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for differential heparin responsiveness in atherosclerosis; prospective studies needed before clinical consideration.
Heparin administered intravenously increases the translucence of plasma during alimentary lipemia. This apparently is solely a physical change. This article reports observations concerning this phenomenon in normal persons and atherosclerotic patients. For purposes of maximal sensitivity, exceedingly small amounts of heparin are used, and distinct differences between the normal and the atherosclerotic individuals are noted, with the atherosclerotic failing to clear well on the same empiric dose of heparin as the normal persons. An unexpected observation was that the normal men developed a significantly greater degree of lipemia than did normal women after ingestion of the same fat meal.
No takes yet. Share an insight, caveat, or question.
Block et al. (1951) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: